Epstein Secrets

to fight COVID-19, suggesting they can help keep patients out of the hospital and possibly prevent illness in some uninfected people." On Tuesday, Eli Lilly said that a "two-antibody combo reduced the risk of hospitalizations or death by 70% in newly diagnosed, non-hospitalized COVID-19 patients at high

erall total doses to 600 million, with delivery expected by summer. The previous purchase target was 400 million doses." The Washington Post (1/26, Al, Stanley-Becker, 10.52M) reports both companies were "cautious in public statements, though people knowledgeable about the negotiations said formal deals were immi

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "

t Journal (10/8, Lubold, Subscription Publication, 7.57M) and Politico (10/8, Forgey, O'Brien, 4.29M) also report, while the Washington Post (10/8, Al, Stanley-Becker, Helderman, Dawsey, Gardner, 14.2M) looks at the spread of COVID from the Barrett event. The Washington Post (10/8, Fadulu, Cox, Schneider, Chason,

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "

t Journal (10/8, Lubold, Subscription Publication, 7.57M) and Politico (10/8, Forgey, O'Brien, 4.29M) also report, while the Washington Post (10/8, Al, Stanley-Becker, Helderman, Dawsey, Gardner, 14.2M) looks at the spread of COVID from the Barrett event. The Washington Post (10/8, Fadulu, Cox, Schneider, Chason,